Clinical Trial: A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07655518) titled 'A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants' on May 29.

Brief Summary: The purpose of this study is to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants

Study Start Date: June 08

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: BMS-986521

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Squibb

Published by HT Digital Content Services with permission from Health Daily Digest....